Effects of angiotensin II and antagonists on AT 1 receptor expression in mesangial cells

By Chansel D.   Vandermeersch S.   Llorens-Cortes C.   Ardaillou R.  

European Journal of Pharmacology, Vol. 384, Iss. 2, 1999-11 ,pp. : 223-230

Elsevier

Access to resources Recommend Favorite

Radioligands for the Angiotensin II Subtype 1 (AT1) Receptor

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 16, 2010-11 ,pp. : 1585-1599

Bentham Science Publishers

Access to resources Recommend Favorite

Interleukin-1 inhibits angiotensin II-stimulated protein kinase B pathway in renal mesangial cells via the inducible nitric oxide synthase

By Rolz W.   Xin C.   Ren S.   Pfeilschifter J.   Huwiler A.  

European Journal of Pharmacology, Vol. 442, Iss. 3, 2002-05 ,pp. : 195-203

Elsevier

Access to resources Recommend Favorite

Telmisartan, an Angiotensin II Type 1 Receptor Blocker, Inhibits Advanced Glycation End-product (AGE)-induced Monocyte Chemoattractant Protein-1 Expression in Mesangial Cells Through Downregulation of Receptor for AGEs via Peroxisome Proliferator-activated Receptor-γ Activation

By Matsui T   Yamagishi S   Ueda S   Nakamura K   Imaizumi T   Takeuchi M   Inoue H  

The Journal of International Medical Research, Vol. 35, Iss. 4, 2007-07 ,pp. : 482-489

Field House Publishing

Access to resources Recommend Favorite

p38 stress-activated protein kinase inhibitor reverses bradykinin B 1 receptor-mediated component of inflammatory hyperalgesia

By Ganju P.   Davis A.   Patel S.   Nunez X.   Fox A.  

European Journal of Pharmacology, Vol. 421, Iss. 3, 2001-06 ,pp. : 191-199

Elsevier

Access to resources Recommend Favorite